1.38 FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

News


<< back

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Date: 2023-10-31 [news.yahoo.com]

READ THE FULL NEWS >>
×